doc. MUDr. Daniela Žáčková, Ph.D.

2024

• Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data

  BELOHLAVKOVA Petra ŽÁČKOVÁ Daniela KLAMOVA Hana FABER Edgar KARAS Michal STEJSKAL Lukas CMUNT Eduard CERNA Olga JEŽÍŠKOVÁ Ivana MACHOVA POLAKOVA Katerina ZAK Pavel JURKOVÁ Tereza CHRÁPAVÁ Marika MAYER Jiří

  Article in Periodical

  Cancer Medicine, year: 2024, volume: 13, edition: 17, DOI

• De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors

  HORŇÁK Tomáš MAYER Jiří ČIČÁTKOVÁ Petra SEMERÁD Lukáš KVETKOVÁ Anežka KLAMOVA Hana FABER Edgar BELOHLAVKOVA Petra KARAS Michal STEJSKAL Lukas CMUNT Eduard CERNA Olga SRBOVA Dana ZIZKOVA Hana VRABLOVA Lucia SKOUMALOVA Ivana VOGLOVA Jaroslava JURKOVA Tereza CHRAPAVA Marika JURČEK Tomáš JEŽÍŠKOVÁ Ivana JAROŠOVÁ Marie MACHOVA POLAKOVA Katerina PAPAJIK Tomas ZAK Pavel JINDRA Pavel ŽÁČKOVÁ Daniela

  Article in Periodical

  American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI

• Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy

  KNIGHT Andrea PISKÁČEK Martin TOMANDLOVÁ Marie SLAMEČKOVÁ Tereza PROCHÁZKOVÁ Jiřina ŽÁČKOVÁ Daniela MAYER Jiří

  Appeared in Conference without Proceedings

  Year: 2024, type: Appeared in Conference without Proceedings

• Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

  EFFICACE Fabio MAHON Francois-Xavier RICHTER Johan PICIOCCHI Alfonso CIPRIANI Marta NICOLINI Franck E MAYER Jiří ŽÁČKOVÁ Daniela JANSSEN Jeroen J W M PANAYIOTIDIS Panayiotis VESTERGAARD Hanne KOSKENVESA Perttu ALMEIDA Antonio HJORTH-HANSEN Henrik MARTINEZ-LOPEZ Joaquin OLSSON-STROMBERG Ulla HOCHHAUS Andreas BERGER Marc G ETIENNE Gabriel KLAMOVA Hana FABER Edgar ROUSSELOT Philippe PFIRRMANN Markus SAUSSELE Susanne

  Article in Periodical

  Leukemia, year: 2024, volume: 38, edition: 8, DOI

• Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

  BRIOLI Annamaria LOMAIA Elza FABISCH Christian SACHA Tomasz KLAMOVA Hana MOROZOVA Elena GOLOS Aleksandra ERNST Philipp OLSSON-STROMBERG Ulla ŽÁČKOVÁ Daniela NICOLINI Franck E BAO Han CASTAGNETTI Fausto PATKOWSKA Elzbieta MAYER Jiří HIRSCHBUEHL Klaus PODGORNIK Helena PACZKOWSKA Edyta PARRY Anne ERNST Thomas VOSKANYAN Astghik SZCZEPANEK Elzbieta SAUSSELE Susanne FRANKE Georg-Nikolaus KIANI Alexander FABER Edgar KRAUSE Stefan CASADO Luis Felipe LEWANDOWSKI Krzysztof EDER Matthias ANHUT Peter GIL Justyna SUEDHOFF Thomas HEBART Holger HEIBL Sonja PFIRRMANN Markus HOCHHAUS Andreas LAUSEKER Michael

  Article in Periodical

  Leukemia, year: 2024, volume: 38, edition: 5, DOI

• Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes

  PERUSINI Maria Agustina ŽÁČKOVÁ Daniela KIM TaeHyung PAGNANO Katia B B PAVLOVSKY Carolina JEŽÍŠKOVÁ Ivana KVETKOVÁ Anežka JURČEK Tomáš KIM Jaeyoon John YOO Young Seok YI Seongyoon LEE Hyewon KIM Kyoung Ha CHANG Myunghee JOSE-MARIO Capo-Chichi MEDEIROS Jessie ARRUDA Andrea MINDEN Mark D ZHANG Zhaolei ABELSON Sagi MAYER Jiří KIM Dennis Dong Hwan

  Article in Periodical

  Blood advances, year: 2024, volume: 8, edition: 10, DOI

• The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

  POLAKOVA Katerina Machova ALBEER Ali POLIVKOVA Vaclava KRUTSKA Monika VLCANOVA Katerina CURIK Nikola FABARIUS Alice KLAMOVA Hana SPIESS Birgit WALLER Cornelius F BRUEMMENDORF Tim H DENGLER Jolanta KUNZMANN Volker BURCHERT Andreas BELOHLAVKOVA Petra MUSTJOKI Satu FABER Edgar MAYER Jiří ŽÁČKOVÁ Daniela PANAYIOTIDIS Panayiotis RICHTER Johan HJORTH-HANSEN Henrik KAMINSKA Magdalena PLONKA Magdalena SZCZEPANEK Elzbieta SZAREJKO Monika BOBER Grazyna HUS Iwona GRZYBOWSKA-IZYDORCZYK Olga WASILEWSKA Ewa PACZKOWSKA Edyta NIESIOBEDZKA-KREZEL Joanna GIANNOPOULOS Krzysztof MAHON Francois X SACHA Tomasz SAUSSELE Susanne PFIRRMANN Markus

  Article in Periodical

  Leukemia, year: 2024, volume: 38, edition: 2, DOI

• Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF

  ŽÁČKOVÁ Daniela SEMERÁD Lukáš FABER Edgar KLAMOVÁ Hana STEJSKAL Lukáš BĚLOHLÁVKOVÁ Petra KARAS Michal CMUNT Eduard ČERNÁ Olga PROCHÁZKOVÁ Jiřina ČIČÁTKOVÁ Petra KVETKOVÁ Anežka HORŇÁK Tomáš SKOUMALOVÁ Ivana SRBOVÁ Dana ŠÁLEK Cyril BUFFA David VOGLOVÁ Jaroslava JURČEK Tomáš FOLTA Adam JEŽÍŠKOVÁ Ivana ŽIŽKOVÁ Hana MACHOVÁ POLÁKOVÁ Kateřina PAPAJÍK Tomáš ŽÁK Pavel JINDRA Pavel SVOBODNÍK Adam ŠTĚPÁNOVÁ Radka MAYER Jiří

  Article in Periodical

  Leukemia, year: 2024, volume: 38, edition: 4, DOI

2023

• Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response

  SEMERÁD Lukáš ŽÁČKOVÁ Daniela BĚLOHLÁVKOVÁ Petra VOGLOVÁ Jaroslava ŽÁK Pavel FABER Edgar PAPAJÍK Tomáš SKOUMALOVÁ I. KARAS M. JINDRA P. KLAMOVÁ H. ŠÁLEK C. SRBOVÁ D. ŽIŽKOVÁ H. STEJSKAL L. ČERNÁ Olga CMUNT Eduard ČIČÁTKOVÁ Petra KVETKOVÁ Anežka HORŇÁK Tomáš JEŽÍŠKOVÁ Ivana JURČEK Tomáš WEINBERGEROVÁ Barbora PROCHÁZKOVÁ Jiřina MACHOVÁ POLÁKOVÁ Kateřina SVOBODNÍK Adam ŠTĚPÁNOVÁ Radka MAYER Jiří

  Conference abstract

  Year: 2023, type: Conference abstract

• Asciminib - nová možnost v léčbě CML

  HORŇÁK Tomáš ČIČÁTKOVÁ Petra ŽÁČKOVÁ Daniela

  Article in Periodical

  Farmakoterapie, year: 2023, volume: 19, edition: 3